Roche: New Test Elevates HIV Diagnostics

Posted: Updated:
Roche says the Elecsys can detect HIV two weeks earlier, because it analyzes antibodies and antigens in the blood. Roche says the Elecsys can detect HIV two weeks earlier, because it analyzes antibodies and antigens in the blood.

Indianapolis was the nerve center for clinical trials that have now led to Roche Diagnostics launching its newest HIV test in the U.S. Roche says the Elecsys HIV combi PT assay is a significant step forward in infectious disease diagnostics; it can detect the virus about two weeks earlier than previous generations and diagnose multiple infectious diseases using a single sample—rather than running multiple tests on different pieces of equipment.

Efficiency is critical when one considers Roche equipment and its assays are responsible for analyzing millions of samples annually inside large reference laboratories. An important feature of the Elecsys assay, or test, is that it’s automated.

“That means less hands-on time required by the medical technologist. It’s our job to streamline their workflow as much as possible by providing efficient testing means,” says Roche Diagnostics Marketing Manager of Infectious Disease Jamie Flanagan. “We’re trying to provide a consolidated approach to the lab; [the Elecsys] has only one touch point on the patient sample. In that patient’s one tube [of blood], it can run all of their infectious disease testing and not have to go back to touch the tube again.”

Unlike earlier generations, the Elecsys can simultaneously test for hepatitis C and syphilis, which are common co-infections. Roche says this reduces the need to obtain multiple samples and use additional analyzers.

“Because HIV, hepatitis c and syphilis are often co-infections in the same patient, it’s important to utilize that one tube to get patient results,” says Flanagan. “It’s a factor in patient satisfaction and patient management from the clinician’s perspective—to have all of the answers from those three assays in one setting and one report.”

The Elecsys, which is a fourth-generation test, can also detect HIV two weeks earlier, because it analyzes antibodies and antigens in the blood; the third-generation assay focuses on only antibodies. The company says another unique factor of the Elecsys is its versatility; the assay can be run in large reference labs or hospital and clinic settings in smaller communities using Roche equipment.

A similar diagnostic tool is helping manage the HIV outbreak in Scott County, caused by the injection drug use of prescription opioids. In the field, the Indiana State Department of Health (ISDH) uses a rapid oral swab for initial detection of the disease, then sends blood samples to the ISDH lab to confirm the diagnosis.

While the state uses a fourth-generation antigen-antibody assay in its lab to detect HIV, the Elecsys—just launched in June of 2017—hasn’t been involved in managing the Scott County outbreak, which surfaced in early 2015. IUPUI Richard M. Fairbanks School of Public Health Associate Professor and Associate Dean of Public Health Practice Dr. Joan Duwve applauds any advances that could expand the public health leaders’ toolbox.

“I recognize the value of scientific achievement, and I’m always excited when science shows us a better way to do things,” says Duwve. “In situations with emerging pathogens, like Ebola or Zika, public health labs actually are first to have access to the latest and greatest diagnostic tests, before they’re even available to commercial labs. Public health labs also work closely with partners at the Centers for Disease Control, other state public health labs or private labs to expand their capacity. With limited public health resources, you have to make sure you’re getting the biggest bang for your buck.”

Roche says its fourth-generation test has been available in other countries for many years and will bring a new level of sensitivity to HIV diagnostics in the U.S.

“The sooner patients are diagnosed in conjunction with the aid of our assay,” says Flanagan, “the sooner they can be treated and receive therapies.” 

Flanagan says a fourth-generation test has been available outside of the U.S. for about 10 years.
Flanagan says Roche’s portfolio of infectious disease assays covers the entire spectrum of volume requirements.
  • Perspectives

    • Market Volatility - Fodder for Financial Fears

      Fact: The value of the stock market goes up and down.  It’s called “market volatility”.  How concerned should you be with a thousand point change in the index? Since your reaction can impact your personal portfolio, it’s most important that you have a good perspective. Significant price movements in the stock market grabbed headlines and captivated media pundits throughout 2018. The last week of the year the market experienced large price swings...

    More

Subscribe

Name:
Company Name:
Email:
Confirm Email:
HTML
INside Edge
Morning Briefing
BigWigs & New Gigs
Life Sciences Indiana
Indiana Connections
INPower
Subscribe
Unsubscribe

Events



  • Most Popular Stories

    • Loeb Stadium Project in Final Design Phase

      The $17 million overhaul of Loeb Stadium in Lafayette is in its final planning stages. The Journal & Courier says the overall design of the project is complete, which includes flipping the field, an additional suite and a new entrance designed to be a more visible landmark. Lafayette Mayor Tony Roswarski unveiled plans for the reimagining of the more than 75-year-old stadium in 2017. The city council earlier this month approved a $17 million bond to fund the project.

    • Hotel, Mattress Company to Launch Collaboration

      Jeffersonville-based Bowles Mattress Co. and West Baden Springs Hotel in Orange County will Monday officially launch their new mattress series. The partnership, first announced last month, will make the mattresses that had previously only been made for the resort available to the public.

    • Eleven Fifty Says State Support Will Bring '100x Return'

      As Eleven Fifty Academy looks to expand statewide, founder Scott Jones is looking to state legislators for support. He says Next Level Jobs legislation two years ago allowed the coding academy to access about $1.5 million to grow its programs, which he says will result in $150 million in Hoosier income over 10 years. Jones is now looking for up to $20 million, which he says could lead to $1.5 billion in Hoosier income over a decade. During an interview on Inside INdiana Business...

    • Silberline Closing Decatur Facility

      Pennsylvania-based Silberline Manufacturing Co. is detailing plans to close its facility in Adams County. In a notice to the state, the company says the closure will result in the layoffs of 50 employees.

    • Two Indiana Banks on Forbes Best List

      Forbes has ranked the best banks in the country and Indiana has placed two on the list. First Merchants Bank finished 2nd, and Old National Bancorp came in at 97. The metrics used by the publication include tangible common equity, return on average assets, net interest margin,  efficiency ratio and net charge-offs as a percentage of total loans.